What's new

Human medicines European public assessment report (EPAR): Xoterna Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 18/09/2013, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Xoterna Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 18/09/2013, Revision: 17, Status: Authorised

Mar 3, 2025 - 17:13
 0
Human medicines European public assessment report (EPAR): Xoterna Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 18/09/2013, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Xoterna Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 18/09/2013, Revision: 17, Status: Authorised
Read More

Tags:

Previous Article

Sanofi bounces midstage ILT2 asset back to Biond Biologics after $125M bet

Next Article

AMEA Power begins construction at Ivory Coast solar project

Related Posts

Regulation (EU) 2024/568: Questions and answers clinic for the Veterinary Industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 February 2025, 15:00 (CET) to 11 February 2025, 16:00 (CET)

Regulation (EU) 2024/568: Questions and answers clinic ...

Feb 13, 2025  0

Agenda of the PRAC meeting 10-13 February 2025

Feb 10, 2025  0

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 4 February 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 4 February 2025, 11:00 (CET) to 4 February 2025, 11:45 (CET)

Questions and answers clinic on Product Management Serv...

Feb 9, 2025  0